Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.mpspharmaa.com | |
Market Cap | 6.08 Cr. | |
Enterprise Value(EV) | 13.13 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.47 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.94 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 1.15 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.76 | Calculated using Price: 3.18 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.91 Cr. | 19,111,400 Shares |
FaceValue | 10 | |
About MPS Pharmaa Ltd. | ||
Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products. |
1 Day |
|
|
1 Week |
|
|
1 Month |
|
|
3 Month |
|
+9.93% |
6 Month |
|
+20.68% |
1 Year |
|
+52.86% |
2 Year |
|
+121.38% |
5 Year |
|
+73.51% |
10 Year |
|
-20.15% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -4.03 | -6.79 | -48.3 | -7.74 | -12.28 | -13.04 | -71.73 | -3.64 | -31.75 | |
Return on Capital Employed (%) | 0.59 | -4.23 | -33.9 | -5.91 | -7.76 | -8.08 | -36.9 | -9.64 | -11.15 | |
Return on Assets (%) | -2.01 | -3.91 | -29.85 | -4.32 | -6.79 | -6.87 | -31.87 | -1.32 | -10.33 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 19 | 19 | 12 | 11 | 10 | 8 | 4 | 4 | 3 | 2 | |
Non Curr. Liab. | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |
Curr. Liab. | 10 | 7 | 8 | 8 | 7 | 7 | 7 | 6 | 7 | 7 | |
Minority Int. | |||||||||||
Equity & Liab. | 32 | 29 | 21 | 19 | 18 | 16 | 11 | 10 | 10 | 10 | |
Non Curr. Assets | 15 | 15 | 14 | 13 | 12 | 11 | 9 | 8 | 8 | 8 | |
Curr. Assets | 17 | 14 | 7 | 7 | 5 | 5 | 2 | 2 | 2 | 2 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 32 | 29 | 21 | 19 | 18 | 16 | 11 | 10 | 10 | 10 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 12 | 1 | 3 | 4 | 1 | 0 | |||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Total Income | 12 | 1 | 3 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | |
Total Expenditure | -11 | -2 | -10 | -5 | -2 | -1 | -4 | -1 | -1 | -1 | |
PBIDT | 1 | 0 | -7 | 0 | -1 | -1 | -4 | 0 | -1 | -1 | |
Interest | -1 | 0 | |||||||||
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | -1 | -1 | -7 | -1 | -1 | -1 | -4 | 0 | -1 | -1 | |
Adjusted EPS | 0 | -1 | -4 | 0 | -1 | -1 | -2 | 0 | -1 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 5 | 2 | 1 | 0 | 0 | 1 | 0 | -1 | -4 | -1 | |
Cash Fr. Inv. | -6 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | |
Cash Fr. Finan. | 2 | -2 | -1 | -1 | 0 | 0 | -1 | 4 | 1 | ||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Thu, 25 Apr 2024
Submission Of Compliance Certificate Pursuant To Regulation 40 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024 Please find enclosed |
Fri, 12 Apr 2024
Confirmation On Non Applicability Of The Criteria Specified Under SEBI Circular No. SEBI/HO/DDHS CIR/P/2018/144 Dated 26Th November 2018Read With Circular No. LIST/COMP/05/2019-20 Dated April 11 2019 Submission of the declaration that our Company " MPS Pharmaa Limited (formerly known as Advik Laboratories Limited) " does not fall under the category of Large Corporate (LC) as on 31st march 2024 . |
Fri, 12 Apr 2024
Submission Of Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Submission of compliance certificate pursuant to Regulation 7(3) of SEBI (LORD) 2015 |
Mon, 29 Apr 2024 |
Closing Below Previous Low |
Close Within 52 Week High Zone |
High Increase in 1 Year |
High Increase in 2 Years |
Close Crossing Last Month Close from Above |